Zenas BioPharma (ZBIO) Short-term Investments (2024 - 2026)

Zenas BioPharma's Short-term Investments history runs 3 years deep, the most recent figure standing at $217.0 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 87.34% year-over-year to $217.0 million; the TTM figure through Mar 2026 stood at $217.0 million (up 87.34% YoY), while the FY2025 annual figure was $232.6 million, up 649.58% from the prior year.
• Short-term Investments was $217.0 million for Q1 2026 at Zenas BioPharma, down from $232.6 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $232.6 million in Q4 2025 to a low of $86000.0 in Q1 2024.
• Historically, Short-term Investments has averaged $111.2 million across 3 years, with a median of $115.8 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Short-term Investments jumped 260437.5% in 2025, then jumped 87.34% in 2026.
• A 3-year view of Short-term Investments shows it stood at $31.0 million in 2024, then surged by 649.58% to $232.6 million in 2025, then dropped by 6.7% to $217.0 million in 2026.
• The last three Short-term Investments figures came in at $217.0 million (Q1 2026), $232.6 million (Q4 2025), and $175.3 million (Q3 2025), per Business Quant data.